Stellanova Therapeutics hiring, advancing clinical pipeline after $15.5M raise

A Houston-based biotechnology firm plans to hire and develop a new discovery platform for its cancer therapeutics after a Series A raise.

Stellanova Therapeutics is developing an antibody that targets fiber blast cells, which protect cancer cells against treatment and promote cancer cell growth. The company is initially targeting aggressive forms of cancer, like pancreatic cancer and triple-negative breast cancer, said Dr. Rosa Hwan g, co-founder of Stellanova and a member of the firm's scientific…

Source: bizjournals.com Health Care:Biotechnology headlines - June 6, 2021 Category: Biotechnology Authors: Chris Mathews Source Type: news